Health Care & Life Sciences » Biotechnology | Omni Bio Pharmaceutical Inc.

Omni Bio Pharmaceutical Inc. | Income Statement

Fiscal year is April-March. All values USD Thousands.
2010
2011
2012
2013
2014
Cost of Goods Sold (COGS) incl. D&A
6.60
6.00
20.50
4.10
4.90
Gross Income
6.60
6.00
20.50
4.10
4.90
SG&A Expense
2,987.60
8,221.30
4,614.80
5,716.10
1,907.50
EBIT
4,489.20
8,227.30
4,635.30
5,720.20
1,912.50
Unusual Expense
528.00
-
141.00
801.30
12.20
Non Operating Income/Expense
-
3.00
621.60
184.00
-
Interest Expense
12.00
-
-
337.00
616.40
Pretax Income
5,025.40
8,225.50
5,395.50
7,454.60
2,516.60
Consolidated Net Income
5,025.40
8,225.50
5,395.50
7,454.60
2,516.60
Net Income
5,025.40
8,225.50
5,395.50
7,454.60
2,516.60
Net Income After Extraordinaries
5,025.40
8,225.50
5,395.50
7,454.60
2,516.60
Net Income Available to Common
5,025.40
8,225.50
5,395.50
7,454.60
2,516.60
EPS (Basic)
0.19
0.29
0.17
0.23
0.07
Basic Shares Outstanding
26,845.20
28,331.60
31,383.40
32,018.60
37,343.60
EPS (Diluted)
0.19
0.29
0.17
0.23
0.07
Diluted Shares Outstanding
26,845.20
28,331.60
31,383.40
32,018.60
37,343.60
EBITDA
4,482.60
8,221.30
4,614.80
5,716.10
1,907.50
Other Operating Expense
1,495.00
-
-
-
-
Non-Operating Interest Income
3.80
4.90
2.30
-
-
Equity in Affiliates (Pretax)
-
-
-
780.20
-

About Omni Bio Pharmaceutical

View Profile
Address
181 West Boardwalk Drive
Fort Collins Colorado 80525
United States
Employees -
Website http://www.omnibiopharma.com
Updated 07/08/2019
Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company, which engaes in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naurally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.